Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2026-02-04
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--SKYT, GORO, STEL, and VTYXVTYX — Ventyx Biosciences Inc
Pharmaceuticals · Pharmaceuticals
$14.00+112.12%Market cap1.00B
- Latest Close
- $14
- 30-Day Move
- +112.1%
- Market Cap
- $1.0B
- Shares Outstanding
- 71,760,000
- P/B Ratio
- 0.61
- ROE
- -53.2%
Analyst consensus: Buy · 15 analysts
VTYXPharmaceuticals / PharmaceuticalsDelayed public snapshot
Ventyx Biosciences Inc
A read-only Alphactor snapshot forVentyx Biosciences Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-03-03
Topline snapshot
Latest Close
$14
30-Day Move
+112.1%
Market Cap
$1.0B
Shares Outstanding
71,760,000
P/B Ratio
0.61
ROE
-53.2%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$14.00
+112.1%last 90 delayed daily bars
Market cap$1.0B
90D High
$25.00
90D Low
$5.74
Avg Volume
4,712,132
What stands out
VTYX is up 112.1% over the last 30 trading days shown on this page.
Latest operating income is $-25M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Dark Pool Short %
45.5%
Fundamentals snapshot
Latest Close
$14
30-Day Move
+112.1%
Market Cap
$1.0B
Shares Outstanding
71,760,000
P/B Ratio
0.61
ROE
-53.2%
ROA
-48.9%
Debt / Equity
0
Current Ratio
17.97
Latest Revenue
$0
Financial statement snapshot
Revenue
$0
Gross Profit
--
Operating Income
$-25M
Net Income
$-23M
Gross Margin
--
Net Margin
--
Current Ratio
17.97
Debt / Equity
0.00
Quality snapshot
Altman Z
23.08
Safe
Piotroski
4
Moderate (4-6)
Cash Conversion
0.97x
Rule of 40
--
Insufficient data
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2021-12-31 | $0 | $-67M | $-84M | $-39M |
| 2022-12-31 | $0 | $-113M | $-108M | $-99M |
| 2023-12-31 | $0 | $-208M | $-193M | $-167M |
| 2024-12-31 | $0 | $-148M | $-135M | $-131M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-02-03
Halper Sadeh LLC is Investigating STEL, CLBK, NFBK, VTYX on Behalf of ShareholdersPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2026-01-23
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VTYX, ALEX, RVYL, and FFWMPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-01-21
Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their RightsPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-01-21
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX)After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$463,300.38
Buys
0
Sells
2
Buy Value
$0
Sell Value
$463,300.38
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-04 | Gonzales Roy | D | 70,000 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 37,500 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 35,000 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 12,500 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 17,500 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 109,200 | $0.00 |
| 2026-03-04 | Gonzales Roy | D | 5,313 | $0.00 |
| 2026-03-04 | Forman Mark S | D | 350,000 | $0.00 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2,014,966 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 694,497 | 0.01% | 2025-12-31 |
| BlackRock Funds-BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO | 603,440 | 0.01% | 2025-11-30 |
| iShares Trust-iShares Biotechnology ETF | 472,766 | 0.01% | 2025-12-31 |
| Delaware Group Equity Funds IV-Nomura Healthcare Fund | 430,000 | 0.01% | 2025-12-31 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 409,356 | 0.01% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 336,065 | 0.00% | 2026-01-31 |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 309,527 | 0.00% | 2025-11-30 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Invesco
Filed 2026-02-19
--
--
Vanguard Group
Filed 2026-01-29
$36M
+4.6%
BlackRock
Filed 2024-05-10
$21M
--
D.E. Shaw
Filed 2026-02-17
$15M
+218.6%
Citadel Advisors
Filed 2026-02-17
$14M
--
Goldman Sachs
Filed 2026-02-10
$11M
+209.1%
Marshall Wace
Filed 2025-11-13
$7M
--
Geode Capital Management
Filed 2026-02-09
$7M
-0.9%
Dark-pool activity snapshot
Analyst consensus?
Rating(?)
3.53
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
15
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.